Literature DB >> 7691945

IL-10 inhibits the synthesis of migration inhibitory factor and migration inhibitory factor-mediated macrophage activation.

J Wu1, F Q Cunha, F Y Liew, W Y Weiser.   

Abstract

IL-10, in addition to being a cytokine synthesis-inhibitory factor, is a cytokine that exerts multiple effects on various cell types. Recombinant human migration inhibitory factor (MIF) inhibits the migration of human monocytes as well as that of guinea pig and murine macrophages. In addition, it has recently been shown to activate human monocyte-derived macrophages to suppress the growth of and/or kill both intracellular parasites and extracellular tumor targets in vitro and to have adjuvant activity in vivo. In this study, we examined the interactions between IL-10 and rMIF. We demonstrate that IL-10 reduces the production of MIF from T cells and abolishes rMIF-mediated migration inhibition of human monocytes. Incubation of IL-10 together with rMIF diminishes rMIF-induced intracellular killing of Leishmania donovani by human monocyte-derived macrophages and inhibits nitric oxide production and nitric oxide synthase activity by murine macrophages.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7691945

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Temporal effect of tumor necrosis factor alpha on murine macrophages infected with Mycobacterium avium.

Authors:  I S Eriks; C L Emerson
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

2.  Cytokine involvement in immunomodulatory activity affected by Candida albicans mannan.

Authors:  Y Wang; S P Li; S A Moser; K L Bost; J E Domer
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

Review 3.  The Role of MIF and IL-10 as Molecular Yin-Yang in the Modulation of the Host Immune Microenvironment During Infections: African Trypanosome Infections as a Paradigm.

Authors:  Benoit Stijlemans; Maxime Schoovaerts; Patrick De Baetselier; Stefan Magez; Carl De Trez
Journal:  Front Immunol       Date:  2022-04-07       Impact factor: 8.786

4.  Macrophage migration inhibitory factor stimulates interleukin-17 expression and production in lymph node cells.

Authors:  Ivana Stojanović; Tamara Cvjetićanin; Sandra Lazaroski; Stanislava Stosić-Grujicić; Djordje Miljković
Journal:  Immunology       Date:  2008-06-20       Impact factor: 7.397

Review 5.  The role of macrophage migration inhibitory factor on glucose metabolism and diabetes.

Authors:  C Toso; J A Emamaullee; S Merani; A M J Shapiro
Journal:  Diabetologia       Date:  2008-07-09       Impact factor: 10.122

6.  The involvement of TLR2 and TLR4 in cytokine and nitric oxide production in visceral leishmaniasis patients before and after treatment with anti-leishmanial drugs.

Authors:  Mariana Gatto; Mariana Miziara de Abreu; Karen Ingrid Tasca; Marjorie de Assis Golim; Laura Denise Mendes da Silva; José Cláudio Simão; Carlos Magno Castelo Branco Fortaleza; Ângela Maria Victoriano de Campos Soares; Sueli Aparecida Calvi
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

7.  Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjögren's syndrome.

Authors:  Peter Willeke; Markus Gaubitz; Heiko Schotte; Christian Maaser; Wolfram Domschke; Bernhard Schlüter; Heidemarie Becker
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

8.  Lack of RNase L attenuates macrophage functions.

Authors:  Xin Yi; Chun Zeng; Hongli Liu; Xiaoli Chen; Ping Zhang; Boo Seok Yun; Ge Jin; Aimin Zhou
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

9.  Role of the immune system in the peritoneal tumor spread of high grade serous ovarian cancer.

Authors:  Katharina Auer; Anna Bachmayr-Heyda; Nyamdelger Sukhbaatar; Stefanie Aust; Klaus G Schmetterer; Samuel M Meier; Christopher Gerner; Christoph Grimm; Reinhard Horvat; Dietmar Pils
Journal:  Oncotarget       Date:  2016-09-20

10.  Combined in vitro IL-12 and IL-15 stimulation promotes cellular immune response in dogs with visceral leishmaniasis.

Authors:  Sidnei Ferro Costa; Vinícius Oliveira Gomes; Marilene Oliveira Dos Santos Maciel; Larissa Martins Melo; Gabriela Lovizutto Venturin; Jaqueline Poleto Bragato; Gabriela Torres Rebech; Catiule de Oliveira Santos; Bárbara Maria Nascimento de Oliveira; Geraldo Gileno de Sá Oliveira; Valéria Marçal Felix de Lima
Journal:  PLoS Negl Trop Dis       Date:  2020-01-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.